S-equol supplement (PharmaVite) success in lipids trial - 26-Mar-2012

A 12-week treatment of the fermented soy germ-based nutritional supplement containing S-equol from PharmaVite significantly lowered hemoglobin A1c (HbA1c), LDL cholesterol and improved vascular stiffness, all factors that occur as part of Metabolic Syndrome, according to a first-of-its-kind peer-reviewed study reported in a poster at the Women's Health 2012 annual meeting.

Related News

Related Nutrition and Dietetics Information

Related Nutrition and Dietetics Drugs

Back to top

Latest News

19 Jun 2013
19 Jun 2013
19 Jun 2013